LifeMD/$LFMD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About LifeMD
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
Ticker
$LFMD
Sector
Primary listing
Employees
350
Headquarters
Website
LifeMD Metrics
BasicAdvanced
$191M
15.97
$0.25
2.01
-
Price and volume
Market cap
$191M
Beta
2.01
52-week high
$15.84
52-week low
$2.56
Average daily volume
1.2M
Financial strength
Current ratio
1.247
Quick ratio
1.109
Long term debt to equity
24.535
Total debt to equity
27.309
Dividend payout ratio (TTM)
21.64%
Interest coverage (TTM)
-5.64%
Profitability
EBITDA (TTM)
-6.71
Gross margin (TTM)
85.72%
Net profit margin (TTM)
7.40%
Operating margin (TTM)
-3.95%
Effective tax rate (TTM)
-0.45%
Revenue per employee (TTM)
$550,000
Management effectiveness
Return on assets (TTM)
-6.71%
Return on equity (TTM)
-131.16%
Valuation
Price to earnings (TTM)
15.969
Price to revenue (TTM)
0.926
Price to book
8.02
Price to tangible book (TTM)
15.11
Price to free cash flow (TTM)
-41.342
Free cash flow yield (TTM)
-2.42%
Free cash flow per share (TTM)
-0.096
Growth
Revenue change (TTM)
-8.66%
Earnings per share change (TTM)
-146.70%
3-year revenue growth (CAGR)
17.69%
10-year revenue growth (CAGR)
66.03%
3-year earnings per share growth (CAGR)
-45.86%
10-year earnings per share growth (CAGR)
37.85%
What the Analysts think about LifeMD
Analyst ratings (Buy, Hold, Sell) for LifeMD stock.
LifeMD Financial Performance
Revenues and expenses
LifeMD Earnings Performance
Company profitability
LifeMD News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for LifeMD stock?
LifeMD (LFMD) has a market cap of $191M as of March 16, 2026.
What is the P/E ratio for LifeMD stock?
The price to earnings (P/E) ratio for LifeMD (LFMD) stock is 15.97 as of March 16, 2026.
Does LifeMD stock pay dividends?
No, LifeMD (LFMD) stock does not pay dividends to its shareholders as of March 16, 2026.
When is the next LifeMD dividend payment date?
LifeMD (LFMD) stock does not pay dividends to its shareholders.
What is the beta indicator for LifeMD?
LifeMD (LFMD) has a beta rating of 2.01. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.